Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Transverse myelitis secondary to Melioidosis; A case report.
Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler's Virus-Induced Demyelinating Disease.
When does multiple sclerosis start? Three case reports and a review of the literature.
Voltage-gated potassium channel antibodies: Game over.
Gray Matter Involvement in Radiologically Isolated Syndrome.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Feature Selection in Order to Extract Multiple Sclerosis Lesions Automatically in 3D Brain Magnetic Resonance Images Using Combination of Support Vector Machine and Genetic Algorithm.
Safety and efficacy of reduced fingolimod dosage treatment.
[Current aspects of therapy conversion for multiple sclerosis].
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
A new model of cuprizone-mediated demyelination/remyelination.
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis.
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis.
Pages
« first
‹ previous
…
410
411
412
413
414
415
416
417
418
…
next ›
last »